Report
FSSAI issues notices over allegedly misleading Celevida GLP+ ads
The Economic Times reports the notices went to Dr Reddy's, Nestle Health Science, Amazon, Flipkart and three other entities.
TLDR
The Economic Times reports that India’s food regulator, FSSAI, issued notices over allegedly misleading advertising for Celevida GLP+. FSSAI questioned claims about maintaining lean muscle during GLP-1/GIP therapies and said the product’s name created a misleading association with those therapies. It also directed the businesses to stop using “100%” on food labels, packaging and promotions.
Combined views
4.1K
1 Source, first seen ago
1 likes